Amish Infantile Epilepsy Syndrome
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
GM3 synthase deficiency is due to biallelic pathogenic variants in ST3GAL5, which encodes a sialyltransferase that synthesizes ganglioside GM3.
|
30185102 |
2018 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype.
|
27232954 |
2016 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
These cases expanded the clinical and genetic spectrum of the ultra-rare disease, GM3 synthase deficiency with ST3GAL5 variants.
|
27232954 |
2016 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.
|
25529582 |
2015 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.
|
24026681 |
2014 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.
|
22990144 |
2013 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency.
|
23436467 |
2013 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.
|
22990144 |
2013 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.
|
15502825 |
2004 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.
|
15502825 |
2004 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.
|
15502825 |
2004 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.
|
15502825 |
2004 |
Amish Infantile Epilepsy Syndrome
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Amish Infantile Epilepsy Syndrome
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Developmental regression
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.
|
25529582 |
2015 |
Developmental regression
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Intellectual Disability
|
0.320 |
Biomarker
|
group |
BEFREE |
ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.
|
30185102 |
2018 |
Intellectual Disability
|
0.320 |
GeneticVariation
|
group |
BEFREE |
Mutations in ST3GAL5 (coding GM3 synthase) were discovered as the basis for severe congenital infantile seizures, whereas mutations in B4GALNT1 (coding GM2/GD2 synthase) are the basis of hereditary spastic paraplegia accompanied by intellectual disability.
|
29747824 |
2018 |
Intellectual Disability
|
0.320 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.
|
25529582 |
2015 |
Choreoathetosis
|
0.110 |
Biomarker
|
disease |
BEFREE |
ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.
|
30185102 |
2018 |
Choreoathetosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral Palsy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|